| Literature DB >> 35664919 |
Yong Li1,2.
Abstract
Background: Preventing in-hospital mortality in patients with ST-segment elevation myocardial infarction (STEMI) is a crucial step.Entities:
Year: 2022 PMID: 35664919 PMCID: PMC9159851 DOI: 10.1155/2022/8758617
Source DB: PubMed Journal: Cardiol Res Pract ISSN: 2090-0597 Impact factor: 1.990
Demographic and clinical characteristics of patient with and without in-hospital mortality.
| Characteristic | Training datasets | Test datasets | Validation datasets | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Original | Downsampling | |||||||||||||||
| Total ( | In-hospital deaths ( | In-hospital survivors ( |
| Total ( | In-hospital deaths ( | In-hospital survivors ( |
| Total ( | In-hospital deaths ( | In-hospital survivors ( |
| Total ( | In-hospital deaths ( | In-hospital survivors ( |
| |
| Age (year, | 65 ± 14 | 72 ± 14 | 64 ± 13 | <0.001 | 68 ± 14 | 72 ± 14 | 64 ± 13 | <0.001 | 64 ± 13 | 71 ± 13 | 64 ± 13 | <0.001 | 64 ± 13 | 71 ± 13 | 64 ± 13 | <0.001 |
| Female sex, | 15109 (33.6) | 2245 (43.4) | 12864 (32.3) | <0.001 | 3940 (38.1) | 2245 (43.4) | 1695 (32.7) | <0.001 | 14211 (32.6) | 2011 (41.1) | 12200 (31.5) | <0.001 | 12827 (31.7) | 1608 (40.2) | 11219 (30.7) | <0.001 |
| Medical history, | ||||||||||||||||
| Hypertension | 32570 (72.4) | 3404 (65.9) | 29166 (73.3) | <0.001 | 7201 (69.6) | 3,404 (65.9) | 3797 (73.3) | <0.001 | 30182 (69.3) | 2,920 (59.7) | 27262 (70.5) | <0.001 | 28411 (70.2) | 2365 (59.1) | 26046 (71.3) | <0.001 |
| Old myocardial infarction | 5260 (11.7) | 530 (10.3) | 4730 (11.9) | 0.001 | 1121 (10.8) | 530 (10.3) | 591 (11.4) | 0.058 | 5088 (11.7) | 406 (8.3) | 4682 (12.1) | 0.001 | 5048 (12.5) | 391 (9.8) | 4657 (12.8) | 0.001 |
| Diabetes | 2479 (5.6) | 495 (9.6) | 1984 (5) | <0.001 | 786 (7.6) | 495 (9.6) | 291 (5.6) | <0.001 | 3844 (8.9) | 751 (15.3) | 3093 (8) | <0.001 | 3804 (9.4) | 705 (17.6) | 3099 (8.5) | <0.001 |
| Cardiogenic shock, | 5632 (12.5) | 2077 (40.2) | 3555 (8.9) | <0.001 | 2542 (24.6) | 2077 (40.2) | 465 (9) | <0.001 | 5658 (13) | 2012 (41.1) | 3646 (9.4) | <0.001 | 5742 (14.2) | 2,024 (50.6) | 3718 (10.2) | <0.001 |
| AFa, | 3173 (7.1) | 414 (8) | 2759 (6.9) | 0.004 | 771 (7.5) | 414 (8) | 357 (6.9) | 0.031 | 3300 (7.6) | 436 (8.9) | 2864 (7.4) | 0.004 | 3204 (7.9) | 379 (9.5) | 2825 (7.8) | 0.004 |
| VFb, | 3403 (7.6) | 975 (18.9) | 2428 (6.1) | <0.001 | 1266 (12.2) | 975 (18.9) | 291 (5.6) | <0.001 | 3431 (7.9) | 1010 (20.6) | 2421 (6.3) | <0.001 | 3336 (8.2) | 931 (23.3) | 2405 (6.6) | <0.001 |
| In-hospital bleeding, | 1053 (2.3) | 343 (6.6) | 710 (1.8) | <0.001 | 429 (4.1) | 343 (6.6) | 86 (1.6) | <0.001 | 822 (1.9) | 306 (6.3) | 516 (1.3) | <0.001 | 643 (1.6) | 296 (7.4) | 347 (1) | <0.001 |
| III AVBc, | 1136 (2.5) | 228 (4.4) | 908 (2.3) | <0.001 | 357 (3.5) | 228 (4.4) | 129 (2.5) | <0.001 | 1158 (2.7) | 236 (4.8) | 922 (2.4) | <0.001 | 1187 (2.9) | 267 (6.7) | 920 (2.5) | <0.001 |
| II AVBc, | 332 (0.7) | 31 (0.6) | 301 (0.8) | 0.219 | 68 (0.7) | 31 (0.6) | 37 (0.7) | 0.470 | 321 (0.7) | 31 (0.6) | 290 (0.7) | 0.370 | 313 (0.8) | 29 (0.7) | 284 (0.8) | 0.715 |
| I AVBc, | 364 (0.8) | 46 (0.9) | 318 (0.8) | 0.490 | 87 (0.8) | 46 (0.9) | 41 (0.8) | 0.585 | 369 (0.8) | 40 (0.8) | 329 (0.9) | 0.811 | 369 (0.9) | 30 (0.7) | 339 (0.9) | 0.259 |
| PCId, | 29110 (64.7) | 1611 (31.2) | 27499 (69) | <0.001 | 5158 (49.9) | 1611 (31.2) | 3547 (68.5) | <0.001 | 29364 (67.4) | 1677 (34.3) | 27687 (71.6) | <0.001 | 29246 (72.2) | 1,595 (39.9) | 27651 (75.8) | <0.001 |
| CABGe, | 2397 (5.3) | 148 (2.9) | 2249 (5.6) | <0.001 | 442 (4.3) | 148 (2.9) | 294 (5.7) | <0.001 | 2244 (5.1) | 166 (3.4) | 2078 (5.4) | <0.001 | 1940 (4.8) | 129 (3.2) | 1811 (5) | <0.001 |
aAF, atrial fibrillation. bVF, ventricular fibrillation. cAVB, atrioventricular block. dPCI, underwent percutaneous coronary intervention during hospitalization. eCABG, underwent coronary artery bypass grafting during hospitalization.
Predictor of in-hospital mortality obtained from multivariable logistic regression models in the training datasets.
| In-hospital mortality | Odds ratio | Coef | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Odds ratio | Std. error |
|
| 95% Conf. interval | Coef. | Std. error |
|
| 95% CI Conf. interval | |
| Age | 1.035432 | 0.0013867 | 26.00 | <0.001 | 1.032718∼1.038153 | 0.0348187 | 0.0013393 | 26.00 | <0.001 | 0.0321938∼0.0374436 |
| Female sex | 1.110608 | 0.0393301 | 2.96 | 0.003 | 1.036136∼1.190431 | 0.1049072 | 0.0354132 | 2.96 | 0.003 | 0.0354987∼0.1743157 |
| Medical history | ||||||||||
| Hypertension | 0.7176797 | 0.0262568 | −9.07 | <0.001 | 0.668019∼0.7710321 | −0.331732 | 0.0365857 | −9.07 | <0.001 | −0.4034387∼−0.2600253 |
| Old myocardial infarction | 0.8129311 | 0.0448676 | −3.75 | <0.001 | 0.7295817∼9058027 | −0.2071089 | 0.0551924 | −3.75 | <0.001 | −0.315284∼−0.0989338 |
| Diabetes | 1.383109 | 0.08354 | 5.37 | <0.001 | 1.228694∼1.55693 | 0.3243337 | 0.0604002 | 5.37 | <0.001 | 0.2059515∼–0.4427159 |
| Cardiogenic shock | 7.635366 | 0.3090266 | 50.23 | <0.001 | 7.053085∼8.265718 | 2.032791 | 0.0404731 | 50.23 | <0.001 | 1.953465∼–2.112117 |
| AFa | 0.6754272 | 0.0420343 | −6.31 | <0.001 | 0.5978678∼0.7630481 | −0.3924099 | 0.0622336 | −6.31 | <0.001 | −0.5143855∼–−0.2704342 |
| VFb | 3.479356 | 0.1777195 | 24.41 | <0.001 | 3.147901∼–3.845713 | 1.246847 | 0.0510783 | 24.41 | <0.001 | 1.146736∼–1.346959 |
| In-hospital bleeding | 2.466731 | 0.1898968 | 11.73 | <0.001 | 2.121258∼–2.868468 | 0.9028937 | 0.0769832 | 11.73 | <0.001 | 0.7520094∼–1.053778 |
| III AVBc | 1.263896 | 0.1131563 | 2.62 | 0.009 | 1.060483∼–1.506327 | 0.2341991 | 0.0895297 | 2.62 | 0.009 | 0.058724∼–0.4096741 |
| PCId | 0.1650676 | 0.0063145 | −47.09 | <0.001 | 0.1531441∼–0.1779195 | −1.8014 | 0.0382538 | −47.09 | <0.001 | −1.876376∼−1.726424 |
| CABGe | 0.1784059 | 0.0171668 | −17.91 | <0.001 | 0.1477419∼–0.2154342 | −1.723694 | 0.0962234 | −17.91 | <0.001 | −1.912288∼−1.5351 |
| _cons | 0.020919 | 0.0020729 | −39.02 | <0.001 | 0.0172263∼–0.0254033 | −3.867096 | 0.0990936 | −39.02 | <0.001 | −4.061316∼−3.672876 |
aAF, atrial fibrillation. bVF, ventricular fibrillation. cAVB, atrioventricular block. dPCI, underwent percutaneous coronary intervention during hospitalization. eCABG, underwent coronary artery bypass grafting during hospitalization.
Confusion matrix and AUC.
| Original to original | Downsampling to original | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TPa | TNb | FPc | FNd | Accuracy | Recall | Specificity | Precision |
|
| AUC | TPa | TNb | FPc | FNd | Accuracy | Recall | Specificity | Precision |
|
| AUC | ||
| Logistic regression | Training | 1039 | 39074 | 753 | 4130 | 0.89 | 0.20 | 0.98 | 0.58 | 0.30 | 0.23 | 0.59 | 4243 | 3775 | 1403 | 926 | 0.77 | 0.82 | 0.73 | 0.75 | 0.78 | 0.81 | 0.77 |
| Test | 987 | 37928 | 758 | 3908 | 0.89 | 0.20 | 0.98 | 0.57 | 0.30 | 0.23 | 0.59 | 3979 | 28944 | 9742 | 916 | 0.76 | 0.81 | 0.75 | 0.29 | 0.43 | 0.60 | 0.78 | |
| Validation | 994 | 35764 | 733 | 3007 | 0.91 | 0.25 | 0.98 | 0.58 | 0.35 | 0.28 | 0.61 | 3294 | 28094 | 8403 | 707 | 0.78 | 0.82 | 0.77 | 0.28 | 0.42 | 0.59 | 0.80 | |
|
| |||||||||||||||||||||||
| Decision tree | Training | 1361 | 39274 | 553 | 3808 | 0.90 | 0.26 | 0.99 | 0.71 | 0.38 | 0.30 | 0.62 | 4316 | 4022 | 1156 | 853 | 0.81 | 0.83 | 0.78 | 0.79 | 0.81 | 0.83 | 0.81 |
| Test | 997 | 37792 | 894 | 3898 | 0.89 | 0.20 | 0.98 | 0.53 | 0.29 | 0.23 | 0.59 | 3735 | 28647 | 10039 | 1160 | 0.74 | 0.76 | 0.74 | 0.27 | 0.40 | 0.56 | 0.75 | |
| Validation | 892 | 35570 | 927 | 3109 | 0.90 | 0.22 | 0.97 | 0.49 | 0.31 | 0.25 | 0.60 | 3094 | 27765 | 8732 | 907 | 0.76 | 0.77 | 0.76 | 0.26 | 0.39 | 0.56 | 0.77 | |
|
| |||||||||||||||||||||||
| Xgboost | Training | 1339 | 39251 | 576 | 3830 | 0.90 | 0.26 | 0.99 | 0.70 | 0.38 | 0.30 | 0.62 | 4496 | 3904 | 1274 | 673 | 0.81 | 0.87 | 0.75 | 0.78 | 0.82 | 0.85 | 0.81 |
| Test | 1041 | 37888 | 798 | 3854 | 0.89 | 0.21 | 0.98 | 0.57 | 0.31 | 0.24 | 0.60 | 4011 | 28110 | 10576 | 884 | 0.74 | 0.82 | 0.73 | 0.27 | 0.41 | 0.59 | 0.77 | |
| Validation | 892 | 35570 | 927 | 3109 | 0.90 | 0.22 | 0.97 | 0.49 | 0.31 | 0.25 | 0.60 | 3306 | 27253 | 9244 | 695 | 0.75 | 0.83 | 0.75 | 0.26 | 0.40 | 0.58 | 0.79 | |
|
| |||||||||||||||||||||||
|
| Training | 370 | 39689 | 138 | 4799 | 0.89 | 0.07 | 1.00 | 0.73 | 0.13 | 0.09 | 0.53 | 3699 | 4128 | 1050 | 1470 | 0.76 | 0.72 | 0.80 | 0.78 | 0.75 | 0.73 | 0.76 |
| Test | 280 | 38539 | 147 | 4615 | 0.89 | 0.06 | 1.00 | 0.66 | 0.11 | 0.07 | 0.53 | 3246 | 31054 | 7632 | 1649 | 0.79 | 0.66 | 0.80 | 0.30 | 0.41 | 0.53 | 0.73 | |
| Validation | 290 | 36332 | 165 | 3711 | 0.90 | 0.07 | 1.00 | 0.64 | 0.13 | 0.09 | 0.53 | 2678 | 29935 | 6562 | 1323 | 0.81 | 0.67 | 0.82 | 0.29 | 0.40 | 0.53 | 0.74 | |
|
| |||||||||||||||||||||||
| Multilayer perceptron | Training | 1082 | 39062 | 765 | 4087 | 0.89 | 0.21 | 0.98 | 0.59 | 0.31 | 0.24 | 0.60 | 4398 | 3634 | 1544 | 771 | 0.78 | 0.85 | 0.70 | 0.74 | 0.79 | 0.83 | 0.78 |
| Test | 1043 | 37929 | 757 | 3852 | 0.89 | 0.21 | 0.98 | 0.58 | 0.31 | 0.24 | 0.60 | 4129 | 28018 | 10668 | 766 | 0.74 | 0.84 | 0.72 | 0.28 | 0.42 | 0.60 | 0.74 | |
| Validation | 804 | 35996 | 501 | 3197 | 0.91 | 0.20 | 0.99 | 0.62 | 0.30 | 0.23 | 0.59 | 3477 | 26476 | 10021 | 524 | 0.74 | 0.87 | 0.73 | 0.26 | 0.40 | 0.59 | 0.74 | |